These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11030179)

  • 21. Endoscopic follow-up and management of Barrett's esophagus in relation to its preneoplastic potential.
    Navarro-Dourdil M; Charro-Calvillo M; Uribarrena-Amézaga R; Sebastián-Domingo JJ
    Hepatogastroenterology; 2014; 61(133):1241-5. PubMed ID: 25436290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endoluminal therapy of neoplastic changes in the gastrointestinal tract: Barrett esophagus--from the viewpoint of the surgeon].
    Stein HJ; Feith M; Siewert JR
    Kongressbd Dtsch Ges Chir Kongr; 2001; 118():147-51. PubMed ID: 11824235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Barrett esophagus: ablative methods of treatment].
    Jung M; Ell C
    Internist (Berl); 2003 Jan; 44(1):52-7. PubMed ID: 12677705
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Barrett's neoplasia: where is the problem?].
    Krugmann J; Vieth M; Neumann H
    Zentralbl Chir; 2014 Aug; 139(4):386-92. PubMed ID: 25119577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Argon plasma coagulation, bipolar cautery, and cryotherapy: ABC's of ablative techniques.
    Dumot JA; Greenwald BD
    Endoscopy; 2008 Dec; 40(12):1026-32. PubMed ID: 19065487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future developments in total Barrett's eradication: the surgeon's view.
    Watson TJ; Peters JH
    Endoscopy; 2008 Dec; 40(12):1048-51. PubMed ID: 19065490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
    Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
    Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced endoscopic therapeutics in Barrett's neoplasia: where are we now and where are we heading?
    Longcroft-Wheaton G; Bhandari P
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):543-5. PubMed ID: 25850665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal disease.
    Pech O
    Gastrointest Endosc; 2013 Sep; 78(3):405-9. PubMed ID: 23948187
    [No Abstract]   [Full Text] [Related]  

  • 34. Esophageal disease.
    Pech O
    Endoscopy; 2013 Sep; 45(9):729-33. PubMed ID: 23990483
    [No Abstract]   [Full Text] [Related]  

  • 35. Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease.
    Lenglinger J; Ringhofer C; Eisler M; Sedivy R; Wrba F; Zacherl J; Cosentini EP; Prager G; Haefner M; Riegler M
    Wien Klin Wochenschr; 2007; 119(13-14):405-11. PubMed ID: 17671821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Observer agreement in the assessment of narrowband imaging system surface patterns in Barrett's esophagus: a multicenter study.
    Singh M; Bansal A; Curvers WL; Kara MA; Wani SB; Alvarez Herrero L; Lynch CR; van Kouwen MC; Peters FT; Keighley JD; Rastogi A; Pondugula K; Kim R; Singh V; Gaddam S; Bergman JJ; Sharma P
    Endoscopy; 2011 Sep; 43(9):745-51. PubMed ID: 21833901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.
    McCarthy M; Wilkinson ML
    Gastrointest Endosc; 1999 Jan; 49(1):129-30. PubMed ID: 10048955
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoscopic mucosal resection and endoscopic submucosal dissection for esophageal dysplasia and carcinoma.
    Inoue H; Minami H; Kaga M; Sato Y; Kudo SE
    Gastrointest Endosc Clin N Am; 2010 Jan; 20(1):25-34, v-vi. PubMed ID: 19951792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.